McClarren Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-81
Closed -$1K 225
2025
Q1
$1K Sell
81
-32
-28% -$492 ﹤0.01% 267
2024
Q4
$1K Buy
113
+30
+36% +$489 ﹤0.01% 190
2024
Q3
$3K Buy
83
+21
+34% +$435 ﹤0.01% 217
2024
Q2
$2K Sell
62
-47
-43% -$934 ﹤0.01% 281
2024
Q1
$3K Buy
109
+2
+2% +$34 ﹤0.01% 265
2023
Q4
$2K Buy
107
+4
+4% +$54 ﹤0.01% 324
2023
Q3
$1K Hold
103
﹤0.01% 310
2023
Q2
$2K Buy
103
+3
+3% +$65 ﹤0.01% 301
2023
Q1
$1K Hold
100
﹤0.01% 308
2022
Q4
$2K Buy
100
+34
+52% +$869 ﹤0.01% 299
2022
Q3
$1K Buy
+66
New +$1.99K ﹤0.01% 291
2022
Q2
Sell
-65
Closed -$1K 188
2022
Q1
$1K Sell
65
-34
-34% -$1.16K ﹤0.01% 268
2021
Q4
$3K Buy
99
+35
+55% +$1.14K ﹤0.01% 283
2021
Q3
$2K Hold
64
﹤0.01% 261
2021
Q2
$1K Buy
+64
New +$2.11K ﹤0.01% 298

Other funds holding OGN

McClarren Financial Advisors's OGN Position: Q2 2025 in Review

McClarren Financial Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 81 shares — an estimated $1K sold.

McClarren Financial Advisors first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $3K in Q3 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • McClarren Financial Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • McClarren Financial Advisors sold 81 Organon & Co shares in Q2 2025, an estimated $1K.
  • McClarren Financial Advisors first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
  • McClarren Financial Advisors's Organon & Co position peaked at $3K in Q3 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on McClarren Financial Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.